SQLite Web: event

seq

Primary key. INTEGER

id

TEXT NOT NULL

kind

TEXT NOT NULL

ts

TEXT NOT NULL

actor

TEXT

subject_entity_ids

TEXT

payload

{"artifact_id":"artf_thesis_8ab300d25b3254e7","evidence_event_ids":["evt_456e480998c2"],"kind":"opportunity_thesis","meta":{"confidence":0.373,"lane":"monitor","morning_holdback":false,"rank_score":0.373,"theme_keys":[],"urgency_reason":"not_urgent","urgent":false},"output_json":{"artifact_kind_detail":"research_thesis","catalysts":[],"confidence":0.373,"decision_reason_codes":["research_thesis"],"headline":"On April 14, 2026, Universe Pharmaceuticals INC adopted the Universe Pharmaceuticals INC 2026 Equity Incentive Plan, with a maximum initial pool of 84,500 ordinary shares and an automatic 10% annual share increase starting in January 2027.","investigation_questions":["What changed vs prior known state is not provided in the signal; no prior plan status or earlier equity plan disclosures are included in...","The filing\u2019s SEC \u201citem\u201d structure and any other 6-K items beyond adoption of the 2026 Equity Incentive Plan are not shown (material_items..."],"portfolio_fit":{"applied":false,"boost":0.0,"exit_risk_flagged":false,"hedge_suggested":null,"matched_holdings":[],"matched_watchlist":[],"stub_version":"v1","why_you":""},"related_tickers":["UPC"],"risk_level":"medium","theme_keys":[],"thesis":"Form 6-K \u00b7 Universe Pharmaceuticals INC \u00b7 Filed 20260416; The SEC filing is a Form 6-K for the month of April 2026.; Universe Pharmaceuticals INC adopted the 2026 Equity Incentive Plan on April 14, 2026. \u2014 Signal convergence: On April 14, 2026, Universe Pharmaceuticals INC adopted the Universe Pharmaceuticals INC 2026 Equity Incentive Plan, with a maximum initial pool of 84,500 ordinary shares and an automatic 10% annual share increase starti"},"ready_at":"2026-04-17T05:17:03.799200+00:00","status":"ready","summary":"Form 6-K \u00b7 Universe Pharmaceuticals INC \u00b7 Filed 20260416; The SEC filing is a Form 6-K for the month of April 2026.; Universe Pharmaceuticals INC adopted the 2026 Equity Incentive Plan on April 14, 2026. \u2014 Signal convergence: On April 14, 2026, Universe Pharmaceuticals INC adopted the Universe Pharmaceuticals INC 2026 Equity Incentive Plan, with a maximum in","title":"[THESIS] UPC \u2014 On April 14, 2026, Universe Pharmaceuticals INC adopted the Universe Pharmaceuticals INC 2026 Equity Incentive Plan, with a maximum initial pool of 84,500 ordinary shares and an automat","updated_at":"2026-04-17T05:17:03.799200+00:00"}

TEXT NOT NULL

source_ref

TEXT

confidence

REAL (default 0.0

dedupe_key

TEXT

episode_id

TEXT

created_at

TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')

event_store.db — events

Update row 62489 in events